Two Onc Docs podcast

Metastatic Non-Small Cell Lung Cancer 2026 UPDATE

14/09/2026
0:00
13:29
Reculer de 15 secondes
Avancer de 15 secondes

 This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has  significantly expanded.

D'autres épisodes de "Two Onc Docs"